Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
1100
Trial Sponsor
Clinical Trial Start Date
2006
0Primary Completion Date
2008
0Study Completion Date
2009
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Drug0
Interventional Trial Phase
Phase 20
Participating Facility
Official Name
A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy0
Last Updated
November 1, 2012
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Other attributes
Intervention Treatment
SB-5090
Normal Saline0
Study summary
The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
